Perturbation-specific transcriptional mapping for unbiased target elucidation of antibiotics.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
05 Nov 2024
Historique:
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 28 10 2024
Statut: ppublish

Résumé

The rising prevalence of antibiotic resistance threatens human health. While more sophisticated strategies for antibiotic discovery are being developed, target elucidation of new chemical entities remains challenging. In the postgenomic era, expression profiling can play an important role in mechanism-of-action (MOA) prediction by reporting on the cellular response to perturbation. However, the broad application of transcriptomics has yet to fulfill its promise of transforming target elucidation due to challenges in identifying the most relevant, direct responses to target inhibition. We developed an unbiased strategy for MOA prediction, called perturbation-specific transcriptional mapping (PerSpecTM), in which large-throughput expression profiling of wild-type or hypomorphic mutants, depleted for essential targets, enables a computational strategy to address this challenge. We applied PerSpecTM to perform reference-based MOA prediction based on the principle that similar perturbations, whether chemical or genetic, will elicit similar transcriptional responses. Using this approach, we elucidated the MOAs of three molecules with activity against

Identifiants

pubmed: 39467118
doi: 10.1073/pnas.2409747121
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2409747121

Subventions

Organisme : HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : NIH-U19AI142780
Organisme : HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : NIH-1K08AI148581

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Keith P Romano (KP)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114.
Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA 02115.

Josephine Bagnall (J)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.

Thulasi Warrier (T)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114.

Jaryd Sullivan (J)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114.
Department of Genetics, Harvard Medical School, Boston, MA 02115.

Kristina Ferrara (K)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114.

Marek Orzechowski (M)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.

Phuong H Nguyen (PH)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114.
Department of Genetics, Harvard Medical School, Boston, MA 02115.

Kyra Raines (K)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114.

Jonathan Livny (J)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.

Noam Shoresh (N)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.

Deborah T Hung (DT)

The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114.
Department of Genetics, Harvard Medical School, Boston, MA 02115.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH